journal
https://read.qxmd.com/read/38653165/blockade-of-neutrophil-extracellular-trap-components-ameliorates-cholestatic-liver-disease-in-mdr2-abcb4-knockout-mice
#1
JOURNAL ARTICLE
Edith Hintermann, Camilla Tondello, Sina Fuchs, Monika Bayer, Josef M Pfeilschifter, Richard Taubert, Martin Mollenhauer, Roland P J Oude Elferink, Michael P Manns, Urs Christen
Primary sclerosing cholangitis (PSC) is an (auto)immune-mediated cholestatic liver disease with a yet unclear etiology. Increasing evidence points to an involvement of neutrophils in chronic liver inflammation and cirrhosis but also liver repair. Here, we investigate the role of the neutrophil extracellular trap (NET) component myeloperoxidase (MPO) and the therapeutic potential of DNase I and of neutrophil elastase (NE) inhibitor GW311616A on disease outcome in the multidrug resistance 2 knockout (Mdr2-/- ) mouse, a PSC animal model...
April 22, 2024: Journal of Autoimmunity
https://read.qxmd.com/read/38653164/impaired-il-6-induced-jak-stat-signaling-in-cd4-t-cells-associates-with-longer-treatment-duration-in-giant-cell-arteritis
#2
JOURNAL ARTICLE
Idil Esen, Maria Sandovici, Peter Heeringa, Annemieke M H Boots, Elisabeth Brouwer, Yannick van Sleen, Wayel Abdulahad
INTRODUCTION: The IL-12-IFNγ-Th1 and the IL-6-IL-23-Th17 axes are considered the dominant pathogenic pathways in Giant Cell Arteritis (GCA). Both pathways signal via activation of the downstream JAK/STAT proteins. We hypothesized that phosphorylated STAT (pSTAT) signatures in circulating immune cells may aid to stratify GCA-patients for personalized treatment. METHODS: To investigate pSTAT expression, PBMCs from treatment-naive GCA-patients (n = 18), infection controls (INF, n = 11) and age-matched healthy controls (HC, n = 15) were stimulated in vitro with IL-6, IL-2, IL-10, IFN-γ, M-CSF or GM-CSF, and stained with CD3, CD4, CD19, CD45RO, pSTAT1, pSTAT3, pSTAT5 antibodies, and analyzed by flow cytometry...
April 22, 2024: Journal of Autoimmunity
https://read.qxmd.com/read/38648706/pparg-mediated-autophagy-activation-alleviates-inflammation-in-rheumatoid-arthritis
#3
JOURNAL ARTICLE
Qishun Geng, Jiahe Xu, Xiaoxue Cao, Zhaoran Wang, Yi Jiao, Wenya Diao, Xing Wang, Zihan Wang, Mengxiao Zhang, Lu Zhao, Lei Yang, Tingting Deng, Bifa Fan, Yuan Xu, Lansi Jia, Cheng Xiao
INTRODUCTION: Rheumatoid arthritis (RA) is a systemic inflammatory autoimmune disease characterized by joint inflammation and bone damage, that not only restricts patient activity but also tends to be accompanied by a series of complications, seriously affecting patient prognosis. Peroxisome proliferator-activated receptor gamma (PPARG), a receptor that controls cellular metabolism, regulates the function of immune cells and stromal cells. Previous studies have shown that PPARG is closely related to the regulation of inflammation...
April 21, 2024: Journal of Autoimmunity
https://read.qxmd.com/read/38643729/multi-omics-study-reveals-different-pathogenesis-of-the-generation-of-skin-lesions-in-sle-and-idle-patients
#4
JOURNAL ARTICLE
Qianwen Li, Chen Jia, Wenjing Pan, Hongmei Liu, Congli Tang, Daniel Weber, Kaili Chen, Hai Long, Miranda L Byrne-Steele, Jian Han, Nongyue He, Rong Xiao, Ming Zhao, Nan Che, Qing Guo, Guangji Gui, Shanshan Li, Henan Si, Shuping Guo, Hongye Liu, Gang Wang, Guannan Zhu, Bin Yang, Yu Wang, Yan Ding, Xianxu Yang, Yoshimura Akihiko, Liwei Lu, Christopher Chang, Vera Chan, Chak-Sing Lau, Hai Qi, Wanli Liu, Song Li, Haijing Wu, Qianjin Lu
Lupus erythematosus (LE) is a heterogeneous, antibody-mediated autoimmune disease. Isolate discoid LE (IDLE) and systematic LE (SLE) are traditionally regarded as the two ends of the spectrum, ranging from skin-limited damage to life-threatening multi-organ involvement. Both belong to LE, but IDLE and SLE differ in appearance of skin lesions, autoantibody panels, pathological changes, treatments, and immunopathogenesis. Is discoid lupus truly a form of LE or is it a completely separate entity? This question has not been fully elucidated...
April 20, 2024: Journal of Autoimmunity
https://read.qxmd.com/read/38643728/uhrf1p-contributes-to-il-17a-mediated-systemic-lupus-erythematosus-via-uhrf1-map4k3-axis
#5
JOURNAL ARTICLE
Huai-Chia Chuang, Kuei-Yuan Lan, Pu-Ming Hsu, Ming-Han Chen, Yi-Ming Chen, Jeng-Hsien Yen, Ben-Yang Liao, Tse-Hua Tan
Inflammatory T cells contribute to the pathogenesis of autoimmune diseases such as systemic lupus erythematosus (SLE). Analysis of the T-cell transcriptomics data of two independent SLE patient cohorts by three machine learning models revealed the pseudogene UHRF1P as a novel SLE biomarker. The pseudogene-encoded UHRF1P protein was overexpressed in peripheral blood T cells of SLE patients. The UHRF1P protein lacks the amino-terminus of its parental UHRF1 protein, resulting in missing the proteasome-binding ubiquitin-like (Ubl) domain of UHRF1...
April 20, 2024: Journal of Autoimmunity
https://read.qxmd.com/read/38642508/anti-u1rnp-antibodies-are-associated-with-a-distinct-clinical-phenotype-and-a-worse-survival-in-patients-with-systemic-sclerosis
#6
JOURNAL ARTICLE
Kevin Chevalier, Guillaume Chassagnon, Sarah Leonard-Louis, Pascal Cohen, Bertrand Dunogue, Alexis Regent, Benjamin Thoreau, Luc Mouthon, Benjamin Chaigne
OBJECTIVES: To clarify the impact of anti-U1RNP antibodies on the clinical features and prognosis of patients with SSc. METHODS: We conducted a monocentric case-control, retrospective, longitudinal study. For each patient with SSc and anti-U1RNP antibodies (SSc-RNP+ ), one patient with mixed connective tissue disease (MCTD) and 2 SSc patients without anti-U1RNP antibodies (SSc-RNP- ) were matched for age, sex, and date of inclusion. RESULTS: Sixty-four SSc-RNP+ patients were compared to 128 SSc-RNP- and 64 MCTD patients...
April 19, 2024: Journal of Autoimmunity
https://read.qxmd.com/read/38642507/the-cd318-cd6-axis-limits-type-1-diabetes-islet-autoantigen-specific-human-t-cell-activation
#7
JOURNAL ARTICLE
Jeong-Su Do, David Arribas-Layton, Jemily Juan, Isaac Garcia, Sindhu Saraswathy, Meirigeng Qi, Enrique Montero, Helena Reijonen
CD6 is a glycoprotein expressed on CD4 and CD8 T cells involved in immunoregulation. CD318 has been identified as a CD6 ligand. The role of CD318 in T cell immunity is restricted as it has only been investigated in a few mice autoimmune models but not in human diseases. CD318 expression was thought to be limited to mesenchymal-epithelial cells and, therefore, contribute to CD6-mediated T cell activation in the CD318-expressing tissue rather than through interaction with antigen-presenting cells. Here, we report CD318 expression in a subpopulation of CD318+ myeloid dendritic (mDC), whereas the other peripheral blood populations were CD318 negative...
April 19, 2024: Journal of Autoimmunity
https://read.qxmd.com/read/38581915/interleukin-15-is-a-hair-follicle-immune-privilege-guardian
#8
JOURNAL ARTICLE
Takahiro Suzuki, Jérémy Chéret, Fernanda S Dinelli, Ali Rajabi-Estarabadi, Aysun Akhundlu, Dana-Lee Demetrius, Jennifer Gherardini, Aviad Keren, Matthew Harries, Jose Rodriguez-Feliz, Gorana Epstein-Kuka, Wendy Lee, Talveen Purba, Amos Gilhar, Ralf Paus
The autoimmunity-promoting cytokine, Interleukin-15 (IL-15), is often claimed to be a key pathogenic cytokine in alopecia areata (AA). Yet, rhIL-15 promotes human hair follicle (HF) growth ex vivo. We have asked whether the expression of IL-15 and its receptor (IL-15R) isoforms is altered in human AA and how IL-15 impacts on human HF immune privilege (HF-IP) in the presence/absence of interferon-γ (IFNγ), the well-documented key AA-pathogenic cytokine, and on hair regrowth after experimental AA induction in vivo...
April 5, 2024: Journal of Autoimmunity
https://read.qxmd.com/read/38574420/peripheral-helper-t-cells-in-human-diseases
#9
REVIEW
Xueyang Zou, Feifei Huo, Lulu Sun, Jing Huang
Peripheral helper T cells (Tph) are a specialized subset of CD4+ T cells with the ability to help B cells and induce antibody production. Although usually located in ectopic lymphoid-like structures (ELS), inside the peripheral blood, Tph cells can also be identified. The aberrant proliferation and functions of Tph cells are commonly found in the patients with disease. In this review, first we will summarize the biological characteristics of Tph cells, such as the expression of surface molecules, transcription factors and cytokines, and discuss its B cell help functions...
April 3, 2024: Journal of Autoimmunity
https://read.qxmd.com/read/38554656/characterization-of-th17-tissue-resident-memory-cells-in-non-inflamed-intestinal-tissue-of-crohn-s-disease-patients
#10
JOURNAL ARTICLE
Yoonho Lee, Jiwon Baek, Sojung Park, Yongjae Kim, Sung Wook Hwang, Jong Lyul Lee, Sang Hyoung Park, Jihun Kim, Suk-Kyun Yang, Buhm Han, Mi-Na Kweon, Kyuyoung Song, Yong Sik Yoon, Byong Duk Ye, Ho-Su Lee
Crohn's disease (CD) is a chronic inflammatory disorder affecting the bowel wall. Tissue-resident memory T (Trm) cells are implicated in CD, yet their characteristics remain unclear. We aimed to investigate the transcriptional profiles and functional characteristics of Trm cells in the small bowel of CD and their interactions with immune cells. Seven patients with CD and four with ulcerative colitis as controls were included. Single-cell RNA sequencing and paired T cell receptor sequencing assessed T cell subsets and transcriptional signatures in lamina propria (LP) and submucosa/muscularis propria-enriched fractions (SM/MP) from small bowel tissue samples...
March 29, 2024: Journal of Autoimmunity
https://read.qxmd.com/read/38552408/balancing-efficacy-and-safety-of-complement-inhibitors
#11
REVIEW
Kanako Watanabe-Kusunoki, Hans-Joachim Anders
Complement inhibitors have been approved for several immune-mediated diseases and they are considered the next paradigm-shifting approach in the treatment of glomerulonephritis. The hierarchical organization of the complement system offers numerous molecular targets for therapeutic intervention. However, complement is an integral element of host defense and therefore complement inhibition can be associated with serious infectious complications. Here we give a closer look to the hierarchical complement system and how interfering with proximal versus distal or selective versus unselective molecular targets could determine efficacy and safety...
March 28, 2024: Journal of Autoimmunity
https://read.qxmd.com/read/38548579/developmental-drugs-for-sarcoidosis
#12
JOURNAL ARTICLE
Ogugua Ndili Obi, Lesley Ann Saketkoo, Lisa A Maier, Robert P Baughman
Sarcoidosis is a multi-organ granulomatous inflammatory disease of unknown etiology. Over 50% of patients will require treatment at some point in their disease and 10%-30% will develop a chronic progressive disease with pulmonary fibrosis leading to significant morbidity and mortality. Recently published guidelines recommend immunosuppressive therapy for sarcoidosis patients at risk of increased disease-related morbidity and mortality, and in whom disease has negatively impacted quality of life. Prednisone the currently recommended first line therapy is associated with significant toxicity however none of the other guideline recommended steroid sparing therapy is approved by regulatory agencies for use in sarcoidosis, and data in support of their use is weak...
March 28, 2024: Journal of Autoimmunity
https://read.qxmd.com/read/38522129/a-reverse-translational-approach-reveals-the-protective-roles-of-mangifera-indica-in-inflammatory-bowel-disease
#13
JOURNAL ARTICLE
Anella Saviano, Anna Schettino, Nunzia Iaccarino, Adel Abo Mansour, Jenefa Begum, Noemi Marigliano, Federica Raucci, Francesca Romano, Gelsomina Riccardi, Emma Mitidieri, Roberta d'Emmanuele di Villa Bianca, Ivana Bello, Elisabetta Panza, Martina Smimmo, Valentina Vellecco, Peter Rimmer, Jonathan Cheesbrough, Zhaogong Zhi, Tariq H Iqbal, Stefano Pieretti, Vincenzo Maria D'Amore, Luciana Marinelli, Valeria La Pietra, Raffaella Sorrentino, Luisa Costa, Francesco Caso, Raffaele Scarpa, Giuseppe Cirino, Antonio Randazzo, Mariarosaria Bucci, Helen Michelle McGettrick, Asif Jilani Iqbal, Francesco Maione
Inflammatory bowel diseases (IBDs) are chronic intestinal disorders often characterized by a dysregulation of T cells, specifically T helper (Th) 1, 17 and T regulatory (Treg) repertoire. Increasing evidence demonstrates that dietary polyphenols from Mangifera indica L. extract (MIE, commonly known as mango) mitigate intestinal inflammation and splenic Th17/Treg ratio. In this study, we aimed to dissect the immunomodulatory and anti-inflammatory properties of MIE using a reverse translational approach, by initially using blood from an adult IBD inception cohort and then investigating the mechanism of action in a preclinical model of T cell-driven colitis...
March 23, 2024: Journal of Autoimmunity
https://read.qxmd.com/read/38521611/kidney-manifestations-of-sarcoidosis
#14
JOURNAL ARTICLE
Francesco Bonella, Adriane Dm Vorselaars, Benjamin Wilde
Renal involvement is a clinically relevant organ manifestation of sarcoidosis, leading to increased morbidity and complications. Although the exact incidence remains unknown, renal disease is likely to occur in up to one third of all sarcoidosis patients. Every patient with newly diagnosed sarcoidosis should receive a renal work-up and screening for disrupted calcium metabolism. Amid various forms of glomerulonephritis, granulomatous interstitial nephritis is the most common one, but it rarely leads to renal impairment...
March 22, 2024: Journal of Autoimmunity
https://read.qxmd.com/read/38520895/quantitative-and-structural-changes-of-blood-platelet-cytoskeleton-proteins-in-multiple-sclerosis-ms
#15
JOURNAL ARTICLE
Angela Dziedzic, Sylwia Michlewska, Piotr Jóźwiak, Janusz Dębski, Michał Seweryn Karbownik, Łukasz Łaczmański, Dorota Kujawa, Sława Glińska, Elżbieta Miller, Marta Niwald, Malgorzata Kloc, Łucja Balcerzak, Joanna Saluk
Epidemiological studies show that cardiovascular events related to platelet hyperactivity remain the leading causes of death among multiple sclerosis (MS) patients. Quantitative or structural changes of platelet cytoskeleton alter their morphology and function. Here, we demonstrated, for the first time, the structural changes in MS platelets that may be related to their hyperactivity. MS platelets were found to form large aggregates compared to control platelets. In contrast to the control, the images of overactivated, irregularly shaped MS platelets show changes in the cytoskeleton architecture, fragmented microtubule rings...
March 22, 2024: Journal of Autoimmunity
https://read.qxmd.com/read/38493674/global-and-regional-epidemiology-of-psoriatic-arthritis-in-patients-with-psoriasis-a-comprehensive-systematic-analysis-and-modelling-study
#16
REVIEW
Zijian Kang, Xueliang Zhang, Yu Du, Sheng-Ming Dai
OBJECTIVES: To provide a comprehensive analysis and modelling of the global epidemiology of psoriatic arthritis (PsA) in patients with psoriasis. METHODS: We reviewed and analysed PsA epidemiology studies over the past 45 years. A Bayesian hierarchical linear mixed model was developed to provide comprehensive age- and sex-specific epidemiologic estimates in different countries and regions. RESULTS: Three hundred and sixty-three studies were systematically reviewed...
March 16, 2024: Journal of Autoimmunity
https://read.qxmd.com/read/38493673/anti-dna-antibody-targeted-d-peptide-nanoparticles-ameliorate-lupus-nephritis-in-mrl-lpr-mice
#17
JOURNAL ARTICLE
Yaqi Wang, Shuang Wang, Wei Liu, Hanjiang Gu, Mai Luo, Tong Xiao, Mingzhu Zhou, Yutong Ran, Shengxiang Xiao, Yumin Xia, Huixia Wang
Peptide ALW (ALWPPNLHAWVP) targeting anti-dsDNA antibodies has shown promising therapeutic effects in alleviating lupus nephritis, but is potentially limited by poor stability and non-kidney targeting. We recently developed a D-form modified ALW, called D-ALW, which has the capacity to widely inhibit pathogenic polyclonal anti-dsDNA antibody reactions. Further modification of D-ALW using PEG-PLGA nanoparticles to enhance good kidney-targeting ability and extend half-life. Here, we demonstrate that the D-form modified ALW maintains higher binding and inhibition efficiencies and achieves higher stability...
March 16, 2024: Journal of Autoimmunity
https://read.qxmd.com/read/38460457/neutrophil-activation-biomarker-pentraxin-3-for-diagnosis-and-monitoring-of-macrophage-activation-syndrome-occurrence-in-adult-onset-still-s-disease
#18
JOURNAL ARTICLE
Dehao Zhu, Longfang Chen, Jianfen Meng, Mengyan Wang, Yuning Ma, Xia Chen, Yu Xiao, Da Yi, Hui Shi, Yue Sun, Honglei Liu, Xiaobing Cheng, Yutong Su, Junna Ye, Huihui Chi, Zhuochao Zhou, Chengde Yang, Jialin Teng, Jinchao Jia, Qiongyi Hu
Macrophage activation syndrome (MAS) is a potentially fatal consequence of adult-onset Still's disease (AOSD), driven by a cytokine storm. Efficient early diagnosis of AOSD-associated MAS requires a sensitive and specific biomarker. In this study, we demonstrated that pentraxin 3 (PTX3), an acute phase protein, was associated with AOSD disease activity and served as a biomarker for AOSD-MAS. PTX3 levels were significantly increased in AOSD patients compared to other autoimmune diseases and healthy controls...
March 8, 2024: Journal of Autoimmunity
https://read.qxmd.com/read/38458076/identifying-the-genetic-association-between-systemic-lupus-erythematosus-and-the-risk-of-autoimmune-liver-diseases
#19
REVIEW
Wei Huang, Tianyu Jin, Wei Zheng, Qiaoqiao Yin, Qiqi Yan, Hongying Pan, Chengan Xu
BACKGROUND: Previous studies on the relationship between systemic lupus erythematosus (SLE) and autoimmune liver diseases (AILDs) are inconclusive. Therefore, we employed Mendelian randomization (MR) to explore the causal associations between SLE and AILDs. METHODS: A two-sample MR analysis was performed using summary-level statistics sourced from genome-wide association study (GWAS) datasets. Inverse-variance weighting (IVW), MR‒Egger, and weighted median (WM) were further supported by several sensitivity analyses...
March 7, 2024: Journal of Autoimmunity
https://read.qxmd.com/read/38458075/targeting-macrophages-with-phosphatidylserine-rich-liposomes-as-a-potential-antigen-specific-immunotherapy-for-type-1-diabetes
#20
JOURNAL ARTICLE
Ivan Garcia-Loza, David Perna-Barrull, Eva Aguilera, Lidia Almenara-Fuentes, Laia Gomez-Muñoz, Daniela Greco, Maria Vila, Miriam Salvado, Montserrat Mancera-Arteu, Michael W Olszowy, Jordi Petriz, Marti Dalmases, Silvia Rodriguez-Vidal, Bruna Barneda-Zahonero, Marta Vives-Pi
Type 1 diabetes (T1D) results from a breakdown in immunological tolerance, with pivotal involvement of antigen-presenting cells. In this context, antigen-specific immunotherapies have been developed to arrest autoimmunity, such as phosphatidylserine (PS)-liposomes. However, the role of certain antigen-presenting cells in immunotherapy, particularly human macrophages (Mφ) in T1D remains elusive. The aim of this study was to determine the role of Mφ in antigen-specific immune tolerance and T1D. To that end, we evaluated Mφ ability to capture apoptotic-body mimicking PS-liposomes in mice and conducted a phenotypic and functional characterisation of four human monocyte-derived Mφ (MoMφ) subpopulations (M0, M1, M2a and M2c) after PS-liposomes uptake...
March 7, 2024: Journal of Autoimmunity
journal
journal
29968
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.